İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

MAHMUT BAKIR KOYUNCU

DOÇENT

MERSİN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 99
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 0 Q2 10 Q3 16 Q4 17
WoS (JCR) Q1 1 Q2 2 Q3 26 Q4 26
TR Index 31 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 99 yayın

Makale listesi

  1. 2025 Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study Medicina DOI 10.3390/medicina61061019 YÖKSİS
  2. 2025 Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma Medicina DOI 10.3390/medicina61081370 YÖKSİS SJR Q2 JCR Q1
  3. 2025 Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI Biomarkers in Medicine DOI 10.1080/17520363.2025.2560797 YÖKSİS SJR Q2 JCR Q3
  4. 2025 Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center Journal of Current Hematology & Oncology Research DOI 10.51271/JCHOR-0063 YÖKSİS TR Index
  5. 2022 Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma Biomarkers in Medicine DOI 10.2217/bmm-2021-0696 YÖKSİS SJR Q3 JCR Q4
  6. 2022 Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma Biomarkers in Medicine DOI 10.2217/bmm-2021-0696 YÖKSİS SJR Q3 JCR Q4
  7. 2022 Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma Biomarkers in Medicine DOI 10.2217/bmm-2021-0696 YÖKSİS SJR Q3 JCR Q4
  8. 2022 Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study Cureus, Inc. DOI 10.7759/cureus.20929 YÖKSİS JCR Q3
  9. 2022 Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study Cureus DOI 10.7759/cureus.20929 YÖKSİS JCR Q3
  10. 2022 Yeni tanı kronik myeloid lösemili hastalarda tiyol/disülfit dengesi ve sokal prognostik skoru ile ilişkisi Mersin Üniversitesi Sağlık Bilimleri Dergisi DOI 10.26559/mersinsbd.951589 YÖKSİS TR Index
  11. 2022 Outcome in patients with peripheral T-cell lymphoma treated with pralatrexate, single center experience Turkish Journal of Internal Medicine DOI 10.46310/tjim.984313 YÖKSİS
  12. 2022 Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study Cureus DOI 10.7759/cureus.20929 YÖKSİS JCR Q3
  13. 2022 Outcome in patients with peripheral T-cell lymphoma treated with pralatrexate, single center experience Turkish Journal of Internal Medicine DOI 10.46310/tjim.984313 YÖKSİS
  14. 2022 Adölesan Dönemde Polikistik Over Sendromu: Fiziksel, Metabolik ve Hormonal Özellikler Düzce Tıp Fakültesi Dergisi DOI 10.18678/dtfd.1089043 YÖKSİS TR Index SJR Q4 JCR Q4
  15. 2022 Outcome in patients with peripheral T-cell lymphoma treated with pralatrexate, single center experience Turkish Journal of Internal Medicine DOI 10.46310/tjim.984313 YÖKSİS
  16. 2022 Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study Cureus DOI 10.7759/cureus.20929 YÖKSİS JCR Q3
  17. 2022 Yeni tanı kronik myeloid lösemili hastalarda tiyol/disülfit dengesi ve sokal prognostik skoru ile ilişkisi Mersin Üniversitesi Sağlık Bilimleri Dergisi DOI 10.26559/mersinsbd.951589 YÖKSİS TR Index
  18. 2022 Outcome in patients with peripheral T-cell lymphoma treated with pralatrexate, single center experience Turkish Journal of Internal Medicine DOI 10.46310/tjim.984313 YÖKSİS
  19. 2022 Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study CUREUS DOI 10.7759/cureus.20929 YÖKSİS JCR Q3
  20. 2022 Yeni tanı kronik myeloid lösemili hastalarda tiyol/disülfit dengesi ve Sokal prognostik skoru ile ilişkisi Mersin Üniversitesi Sağlık Bilimleri Dergisi DOI 10.26559/mersinsbd.951589 YÖKSİS TR Index

Akademisyenlere dön